Key Takeaways
- • Britam Insurance commits up to Sh1.9 billion ($15 million) to invest in fintech and insurtech startups across seven markets over the 2026-2030 strategic planning period, with 20-30 percent of capital sourced from its own balance sheet.
- • The insurer's venture capital arm, BetaLab (established February 2024), will deploy capital in tranches of $5,000 to $50,000 per startup with investment horizons spanning 5-15 years, targeting seed-stage through growth-stage companies.
- • Britam's venture expansion reflects strategic portfolio diversification driven by intensifying competition from non-traditional players, including fintechs and insurtechs disrupting conventional insurance and asset management services.
- • To date, BetaLab has disclosed one investment: a Sh5 million seed funding round in digital lender Oye (June 2025), with additional pipeline investments under development.
- • The initiative addresses a broader market contraction in Kenyan startup funding following several years of elevated investment activity.
Summary
Britam Insurance is expanding its venture capital operations through BetaLab, its incubation hub, committing up to Sh1.9 billion ($15 million) toward financial technology and insurance technology startups across the seven markets where the insurer operates. The investment program, structured to run through 2030, represents a strategic pivot toward portfolio diversification and innovation in response to competitive pressures reshaping the financial services landscape.
According to Simon Wanduga, Britam's head of telco and fintech partnerships, the insurer will contribute 20-30 percent of the total $15 million commitment from its own balance sheet, with the remainder expected to be raised from external venture capitalists and strategic investors. This blended funding approach allows Britam to leverage third-party capital while maintaining operational control over investment decisions and strategic alignment with core business objectives.
BetaLab, established in February 2024, employs a granular investment strategy, deploying between $5,000 and $50,000 per startup with multi-decade investment horizons of 5-15 years. The vehicle targets companies across development stages, from seed-stage through growth phase. The insurer's disclosed investment activity includes a Sh5 million seed funding participation in digital lender Oye in June 2025, with additional transactions in pipeline development.
Wanduga emphasized that Britam faces competition not solely from traditional insurance competitors but increasingly from fintech and insurtech firms disrupting conventional financial services delivery. The venture capital expansion is positioned as a defensive and offensive strategy, enabling Britam to participate in market-shaping innovations while reducing concentration risk in traditional insurance and asset management operations. This move arrives amid a documented slowdown in Kenyan startup funding following years of elevated capital deployment, placing strategic importance on disciplined, patient capital deployment from institutional players like Britam.
According to Simon Wanduga, Britam's head of telco and fintech partnerships, the insurer will contribute 20-30 percent of the total $15 million commitment from its own balance sheet, with the remainder expected to be raised from external venture capitalists and strategic investors. This blended funding approach allows Britam to leverage third-party capital while maintaining operational control over investment decisions and strategic alignment with core business objectives.
BetaLab, established in February 2024, employs a granular investment strategy, deploying between $5,000 and $50,000 per startup with multi-decade investment horizons of 5-15 years. The vehicle targets companies across development stages, from seed-stage through growth phase. The insurer's disclosed investment activity includes a Sh5 million seed funding participation in digital lender Oye in June 2025, with additional transactions in pipeline development.
Wanduga emphasized that Britam faces competition not solely from traditional insurance competitors but increasingly from fintech and insurtech firms disrupting conventional financial services delivery. The venture capital expansion is positioned as a defensive and offensive strategy, enabling Britam to participate in market-shaping innovations while reducing concentration risk in traditional insurance and asset management operations. This move arrives amid a documented slowdown in Kenyan startup funding following years of elevated capital deployment, placing strategic importance on disciplined, patient capital deployment from institutional players like Britam.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.